Trials / Completed
CompletedNCT00960141
A Study Investigating the Effect of Montelukast in Patients With Seasonal Allergic Rhinitis (MK-0476-192)(COMPLETED)
A Multicenter, Double-Blind, Randomized, Parallel-Group Study Investigating the Clinical Effect of Montelukast in Patients With Seasonal Allergic Rhinitis-Fall Study
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 829 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 15 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
A study of the ability of montelukast to improve signs and symptoms of seasonal allergic rhinitis compared with placebo. Loratadine is included in the study as an active control.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | montelukast sodium | montelukast 10 mg tablet, taken orally once daily at bed time for 2 weeks |
| DRUG | Comparator: loratadine | loratadine 10 mg tablet, taken orally once daily at bed time for 2 weeks |
| DRUG | Comparator: placebo | placebo tablet, taken orally once daily at bed time for 2 weeks |
Timeline
- Start date
- 2000-08-01
- Primary completion
- 2000-10-01
- Completion
- 2000-11-01
- First posted
- 2009-08-17
- Last updated
- 2022-02-03
- Results posted
- 2010-06-09
Source: ClinicalTrials.gov record NCT00960141. Inclusion in this directory is not an endorsement.